The effect of L-dopa, noradrenalin and adrenalin on P-388 mouse leukemia, B-16 mouse melanoma and E 0771 mammary carcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000818:Animals; D000970:Antineoplastic Agents; D004353:Drug Evaluation, Preclinical; D004837:Epinephrine / Q000627:therapeutic use*; D005260:Female; D007942:Leukemia, Experimental / Q000188:drug therapy; D007980:Levodopa / Q000627:therapeutic use*; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy*; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009638:Norepinephrine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D007980:Levodopa; D009638:Norepinephrine; D004837:Epinephrine